LJPC Market Cap History



Below is a table of the LJPC market cap history going back to 1/14/2014:

Date LJPC Market Cap
1/14/201436.56M
1/29/201439.15M
3/21/201494.70M
4/29/201473.48M
8/12/2014149.44M
11/7/2014186.98M
2/27/2015309.90M
4/23/2015371.21M
7/31/2015463.67M
10/31/2015455.86M
2/22/2016310.50M
3/31/2016381.69M
4/22/2016364.53M
7/31/2016310.32M
10/31/2016319.45M
3/31/2017660.39M
4/21/2017632.51M
7/21/2017740.91M
10/20/2017771.32M
2/16/2018750.84M
3/31/2018778.88M
4/23/2018791.17M
7/27/2018852.61M
10/19/2018423.94M
2/20/2019158.12M
2/28/2019154.37M
4/25/2019201.89M
7/26/2019229.24M
10/25/2019211.83M
2/3/2020187.51M
4/29/2020189.73M
7/27/2020107.53M
11/3/202099.67M
2/8/2021201.32M
3/1/2021140.23M
4/3/2021119.40M
7/23/2021104.18M
10/22/2021105.69M
2/25/2022102.81M
4/15/2022111.97M
8/1/2022154.61M

Also see: LJPC Shares Outstanding History
and LJPC YTD Return
LJPC Historical Market Cap:
+18.38% CAGR
LJPC Historical Market Cap: +18.38% CAGR

Mouse over chart for data details
1/14/2014 ...8/1/2022
La Jolla Pharmaceutical is focused on the commercialization of therapies. GIAPREZA™ (angiotensin II) injection is a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. XERAVA™ (eravacycline) for injection is a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections. Co. owns various product candidates that are in preclinical development including: TP-6076, an IV formulation of a synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. We show 41 historical shares outstanding datapoints in our LJPC shares outstanding history coverage, used to compute LJPC market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing LJPC market cap history over the course of time is important for investors interested in comparing LJPC's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of LJPC versus a peer is one thing; comparing LJPC market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like LJPC can fluctuate over the course of history. With this page we aim to empower investors researching LJPC by allowing them to research the LJPC market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree LJPC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
La Jolla Pharmaceutical (LJPC) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

LLY Market Cap History
LMAT Market Cap History
LMNX Market Cap History
LNSR Market Cap History
LNTH Market Cap History
LOGC Market Cap History
LOXO Market Cap History
LPCN Market Cap History
LPNT Market Cap History
LPTX Market Cap History
More Healthcare companies »

 

LJPC Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.